Straumann Holding AG EBIT 2012-2024 | SAUHY
Straumann Holding AG annual and quarterly EBIT history from 2012 to 2024. EBIT can be defined as earnings before interest and taxes.
- Straumann Holding AG EBIT for the quarter ending December 31, 2024 was $M, a NAN% increase year-over-year.
- Straumann Holding AG EBIT for the twelve months ending December 31, 2024 was $0M, a NAN% increase year-over-year.
- Straumann Holding AG 2024 annual EBIT was $0.683B, a 49.13% increase from 2023.
- Straumann Holding AG 2023 annual EBIT was $0.458B, a 18.4% decline from 2022.
- Straumann Holding AG 2022 annual EBIT was $0.561B, a 5.5% decline from 2021.
Straumann Holding AG Annual EBIT
(Millions of US $) |
| 2024 |
$683 |
| 2023 |
$458 |
| 2022 |
$561 |
| 2021 |
$594 |
| 2020 |
$167 |
| 2019 |
$390 |
| 2018 |
$350 |
| 2017 |
$288 |
| 2016 |
$231 |
| 2015 |
$180 |
| 2014 |
$162 |
| 2013 |
$122 |
| 2012 |
$63 |
| 2011 |
$87 |
Straumann Holding AG Quarterly EBIT
(Millions of US $) |
| 2024-12-31 |
|
| 2024-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-12-31 |
|
| 2018-12-31 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| 2015-12-31 |
|
| 2014-12-31 |
|
| 2013-12-31 |
|
| 2013-06-30 |
|
| 2012-12-31 |
|
| 2012-06-30 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.198B |
$2.845B |
|
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
|
